Differences between a patient’s true normal range and the population-based reference interval can create problems for doctors ...

Funding from the Children’s Tumor Foundation will enable researchers at the University of Plymouth to pioneer a testing model ...

The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...

If you've ever had a doctor order a blood test for you, chances are that they ran a complete blood count, or CBC. One of the ...

Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP ...

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is ...

The University of Cincinnati’s Ishita Basu, PhD, has been awarded an $810,000 United States Department of Defense grant to ...

A new algorithm eliminates a second rescreen if a newborn falls into the retest category, allowing for earlier intervention, ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

GP practices are facing confusion over different approaches to asthma diagnosis set out in the QOF and in the new UK joint ...

Traditionally, clinicians determine what are called reference intervals by measuring a blood test in a range of healthy people. They usually take the middle 95% of these healthy values and call that ...